Navigation Links
Surviving Healthcare Reform: How Biopharma Companies Can Come Out on Top
Date:11/6/2009

STAMFORD, Conn. and WESTON, Mass., Nov. 6 /PRNewswire/ -- Those biopharmaceutical companies that are able to incorporate innovative and flexible elements into their business models will be best positioned to survive healthcare reform and maintain attractive long-term returns, according to a white paper published today by Cowen Healthcare Royalty Partners, a global healthcare private equity firm, and Health Advances, a leading healthcare strategy firm.

The paper, "Maintaining Attractive Biopharma Returns in the Face of Healthcare Reform", examines key issues at the center of the debate including access to care, controlling costs, drug pricing and value-based healthcare. In addition to discussing the increased pressures biopharma companies face, including the restrictive use of branded drugs for large patient populations and follow-on biologics, the paper outlines new solutions companies can implement to achieve the same levels of return for its investments as it has in the past.

Some of the paper's key findings include:

  • Biopharma companies need to adapt their business models to maintain attractive ROIs such as exploring pay-for-performance relationships with stakeholders, cost-effective care solutions that align incentives, and investing in follow-on biologics and/or generics
  • Investing in pharmacoeconomic competencies and integrating these into clinical development will mitigate reimbursement risk
  • Investing in personalized healthcare and specifically biomarkers will be rewarded
  • Highly differentiated products addressing niche markets will be the least vulnerable even if stringent regulation is passed

Gregory B. Brown, M.D., Co-Founder and Managing Director of Cowen Royalty, commented, "Healthcare reform is a serious issue for biopharma companies who are already feeling pressure from patent expirations, fewer drug approvals and growing development costs. We partnered with Health Advances to bring a new and unique perspective on the healthcare debate especially as it relates to biopharma companies -- the developers of many of our future medicines."

To download a copy of the white paper visit http://www.cowenroyalty.com/content/news/publications-presentations.htm.

About Cowen Healthcare Royalty Partners:

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purchase of royalty interests. The investment team has over 100 years of healthcare related experience including principal investing, structured finance, healthcare industry senior management, Wall Street research and consulting, scientific and clinical experience. For more information, visit www.cowenroyalty.com.

About Health Advances:

Founded in 1992, Health Advances is a leading healthcare strategy firm advising clients in the biopharma, device and diagnostic sectors. Industry executives and investors rely on Health Advances to advise them on their most challenging commercial decisions. For more information regarding our consulting services, visit www.healthadvances.com.

Media Contact:

    Kellie Walsh
    914-315-6072
    kwalsh@kwmcommunications.com

SOURCE Cowen Healthcare Royalty Partners


'/>"/>
SOURCE Cowen Healthcare Royalty Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chemobrain -- the flip side of surviving cancer
2. More Women Surviving After Early Breast Cancer
3. Early Menstruation Lowers Odds of Surviving Ovarian Cancer
4. More Extreme Preemies Surviving
5. Spike TV Goes Into Production of Special Episode of Original Series Surviving Disaster Focused on the Swine Flu and Other Pandemics
6. Surviving lung cancer
7. National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
8. White patients benefit more than blacks in surviving surgical complications at teaching hospitals
9. White Patients Benefit More Than Blacks in Surviving Surgical Complications at Teaching Hospitals
10. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
11. Surviving the Holidays After a Loved Ones Death: Economic Woes Add to Holiday Pressure for People Who Grieve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... A CDC study shows that, although people are taking ... (ages 18 to 29), had at least one case of sunburn within the past year. ... causes people to ignore the issue. However, only recently have people become conscientious of the ...
(Date:7/24/2017)... ... ... Anyone who uses scales know they have limits; a small kitchen scale ... scale to dispense medication. The first example is an issue of capacity, while the ... important to have the right balance for the process. METTLER TOLEDO’s new white paper, ...
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of the nationally ... on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air about an ... China. , The article by Zidor Aldama described the situation in which Chinese children ...
(Date:7/24/2017)... ... 2017 , ... Paul Vitenas, MD, FACS is excited to report that he ... attend Allergan’s recent meeting with their Plastics Advisory Board. As one of the top ... bringing a newly defined structure to the aesthetics market. Dr. Vitenas , along ...
(Date:7/24/2017)... ... July 24, 2017 , ... The Magic Wand® Rechargeable, the ... for favorite sex toy. Created in collaboration with website Kinkly.com, the award was ... voted. The Magic Wand Rechargeable won in stiff competition from brands such as ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... 12, 2017 CarpalAID is a revolutionary new product that ... Carpal tunnel syndrome affects more than 8 million people ... rate of men. The common methods of treating CTS are painful ... hand braces or gloves. ... CarpalAID is a clear patch worn on the ...
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)...  US medical equipment and supply demand is forecast ... Medical Equipment & Supplies: United States , ... increases in demand for medical services – driven in ... supported by gains in disposable personal income – will ... introductions will also drive sales as providers and patients ...
Breaking Medicine Technology: